Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Oct 10, 2017
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2017 PForm 4 → | Oct 10, 3:25 pm EDT | Genius Brands International, Inc.GNUS | Andrew A HeywardChief Executive Officer, Director, 10% Owner | 7,500 | $3.39 | $25,425 | 256,340 | +3.01% | plan? |
| May 11, 2017 PForm 5 → | Oct 10, 12:04 pm EDT | PANAMERA HEALTHCARE CorpPNHT | Curtis Eugene SummersPresident, Director, 10% Owner | 3,220,000 | $0.0077 | $24,794 | 9,660,000 | +50.0% | plan? |
| May 11, 2017 PForm 5 → | Oct 10, 12:05 pm EDT | PANAMERA HEALTHCARE CorpPNHT | Douglas Glenn BakerCFO, Secretary, Treasurer, Director, 10% Owner | 3,220,000 | $0.0077 | $24,794 | 4,340,000 | +288% | plan? |
| Oct 5, 2017 PForm 4 → | Oct 10, 10:01 am EDT | R F INDUSTRIES LTDRFIL | Gerald T GarlandDirector | 10,000 | $2.24 | $22,400 | 20,028 | +99.7% | plan? late |
| Oct 9, 2017 PForm 4 → | Oct 10, 8:00 am EDT | Pershing Gold Corp.PGLC | Barry C HonigDirector, 10% Owner | 3,000 | $3.12 | $9,360 | 1,477,318 | +0.20% | plan? |
| Oct 6, 2017 PForm 4 → | Oct 10, 8:10 am EDT | DelMar Pharmaceuticals, Inc.DMPI | Jeffrey BachaCEO, Director | 10,000 | $0.8725 | $8,725 | 63,697 | +18.6% | plan? |
| Oct 4, 2017 PForm 4 → | Oct 10, 3:27 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident, 10% Owner | 61,000 | $0.0648 | $3,955 | 23,751,189 | +0.26% | plan? late |
| Oct 4, 2017 PForm 4 → | Oct 10, 8:55 am EDT | PEN INC.PENC | Ronald J BermanDirector | 201 | $1.52 | $307 | 250,342 | +0.08% | plan? late |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.